Physician sees home blood pressure monitoring more accurate
DALLAS Accurate blood pressure readings used to diagnose risk of future cardiovascular disease events may be better taken at home as opposed to a clinic setting, Lawrence Krakoff, a doctor with the Department of Medicine, Mount Sinai School of Medicine, wrote in the Nov. 1 issue of American Heart Association’s journal Hypertension.
“Clinical science has clearly shown that blood pressures measured in the clinic are inferior to those measured outside the clinic in ‘real life’ for predicting future cardiovascular mortality and morbidity,” Krakoff wrote, suggesting that more research be done comparing clinic blood pressure measurements alongside home-blood pressure measurements. “Two strategies have been widely studied in this regard: 24-hour ambulatory blood pressure monitoring and home blood pressure recording—both have also been assessed for their role in determining the effectiveness of antihypertensive treatment. Most reports have assessed one or the other modality, but not both,” he wrote. “An orderly and comprehensive comparison of clinic pressures, ambulatory monitoring pressures, and home blood pressures during antihypertensive treatment may yield important insights.”
FDA announces recall of Tyco ReliOn single-use syringes
ROCKVILLE, Md. Food and Drug Administration said Wednesday that Tyco Healthcare Group is recalling a lot of its ReliOn single-use syringes for diabetics.
The recall affects lot number 813900, which contines 100 31-gauge ReliOn hypodermic syringes containing 1 milliliter of U-100 insulin. Tyco distributed 4,710 boxes in the recalled lot, totaling 471,000 individual syringes. Wal-Mart sold the syringes at its stores between Aug. 1 and Oct. 8, and Tyco voluntarily recalled the lot Oct. 9. Wal-Mart has sent letters to 16,500 customers notifying them of the recall and posted an announcement on its Web site.
Can-Am Care distributes the syringes and sells them through Wal-Mart and Sam?s Club stores under the Reli-On brand. The mass-merchandiser has requested that all users of this type of syringe return those that come from the recalled lot.
The FDA said that during the packaging of the syringes, some syringes labeled for use with U-40 insulin were mixed with syringes labeled for use with U-100 insulin and then packaged individually and in boxes as 100 units for use with U-100 insulin. Tyco has received one report of complications due to use of a syringe from the recalled lot.
Medical information leaks prompt added awareness about records security
CHICAGO News reports about high-profile victims of personal medical information security and privacy breaches highlight the need to educate and inform healthcare professionals, their employees, the media and consumers on privacy protection, an professional organization for the health information management industry said Thursday.
The American Health Information Management Association said that educating healthcare professionals on privacy and security issues is an ongoing concern within the health information industry.
“It’s critical for healthcare professionals to receive more education about good privacy practices and appropriate interpretation of HIPAA and other regulations,” AHIMA president Wendy Mangin said.